Lucy Day
Directeur Financier/CFO chez AN2 THERAPEUTICS, INC.
Fortune : 69 830 $ au 30/04/2024
Postes actifs de Lucy Day
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AN2 THERAPEUTICS, INC. | Directeur Financier/CFO | 01/11/2019 | - |
Historique de carrière de Lucy Day
Anciens postes connus de Lucy Day
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ANACOR PHARMACEUTICALS INC | Directeur Financier/CFO | 01/03/2002 | 01/08/2016 |
| Responsable des Ressources Humaines | 01/03/2002 | 01/08/2016 | |
| Centaur Pharmaceuticals, Inc. | Directeur Financier/CFO | 01/02/1994 | 01/01/2002 |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Corporate Officer/Principal | 01/01/1990 | 01/01/1994 |
Formation de Lucy Day
| University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director of Finance/CFO | 3 |
| Human Resources Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AN2 THERAPEUTICS, INC. | Health Technology |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
| Entreprise privées | 2 |
|---|---|
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
| Centaur Pharmaceuticals, Inc. | Health Technology |
